# Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients

> **NCT01100437** · PHASE4 · TERMINATED · sponsor: **Pfizer** · enrollment: 14 (actual)

## Conditions studied

- Chronic Pain

## Interventions

- **DRUG:** EMBEDA™ (morphine sulfate/naltrexone hydrochloride) crush
- **DRUG:** EMBEDA™ (morphine sulfate/naltrexone hydrochloride) whole

## Key facts

- **NCT ID:** NCT01100437
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-04
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2012-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01100437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01100437, "Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01100437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*